Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002
Abnormal Cobalamin-dependent Transmethylation in AIDS-associated Myelopathy
Neurol 58:730-735, Di Rocco,A.,et al, 2002
Symptoms of B12 Deficiency Can Occur in Women of Child Bearing Age Supplemented with Folate
Neurol 58:1572-1573, Drazkowski,J.,et al, 2002
Dietary Intake of Folate and Risk of Stroke in US Men and Women
Stroke 33:1183-1189, Bazzano,L.A.,et al, 2002
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002
Wernicke's Encephalopathy in a Woman on Slimming Diet
Neurol 58:1697-1698, Sechi,G.P.,et al, 2002
Nanging
Lancet 360:384, Ng, J. &Frith, R., 2002
Reversible Chorea and Focal Dystonia in Vitamin B12 Deficiency
NEJM 347:295, Pacchetti,C.,et al, 2002
Leukoaraiosis is Associated with Warfarin-Related Hemorrhage Following Ischemic Stroke
Neurol 59:193-197, Smith,E.E.,et al, 2002
Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002
New Evidence for Stroke Prevention
JAMA 288:1396-1398, Straus,S.E.,et al, 2002
New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002
Clinical Profile of Stroke in 900 Patients with Hypertrophic Cardiomyopathy
J Am Coll Cardiol 39:301-307, Maron,B.J.,et al, 2002
Neurological Complications of Coeliac Disease
Postgrad Med J 78:393-398, Tengah, D.S.N.A.,et al, 2002
Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency
Arch Int Med 161:1534-1541, Hvas,A.,et al, 2001
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Cystic Fibrosis Presenting With Intracerebral Haemorrhage
Lancet 358:1960, Merelle,M.E.,et al, 2001
Oral Anticoagulation for Cerebral Ischemic of Arterial Origin
Neurol 57:1993-1999, Torn,M.,et al, 2001
Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001
Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001
Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001
Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review)
Neurol 56:1143-1153, Knopman,D.S.,et al, 2001
Atrial Fibrillation
NEJM 344:1067-1078, Falk,R.H., 2001
Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube Defects
JAMA 285:2981-2986,3022, Honein,M.A.,et al, 2001
Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke Patients
Stroke 32:1673-1677, Sato,Y.,et al, 2001
Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000
Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Intraspinal Hemorrhage Complicating Oral Anticoagulant Therapy, An Unusual Case of Cervical Hematomyelia and a Review of the Literature
Arch Int Med 160:237-240, Pullarkat,V.A.,et al, 2000
MR Findings in Subacute Combined Degeneration of the Spinal Cord: A Case of Reversible Cervical Myelopathy
AJR 174:863-865, Ravina,B.,et al, 2000
Nitrous Oxide Anesthesia-Associated Myelopathy
ArchNeurol 57:380-382, Marie,R.,et al, 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Shaky-Leg Syndrome and Vitamin B12 Deficiency
NEJM 342:981, Benito-Leon,J.&Porta-Etessam,J., 2000
Safe Feeding Methods in Stroke Patients
Lancet 355:1662-1663, Finestone,H.M., 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Helicobacter pylori -- Is It a Novel Causative Agent in Vitamin B12 Deficiency?
Arch Int Med 160:1349-1353,1229, Kaptan,K.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Helicobacter pylori--Is it a Novel Causative Agent in Vitamin B12 Deficiency?
Arch Int Med 160:1349-1353, 1229, Kaptan,K. et al, 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Acute Neurologic Decompensation in an Infant With Cobalamin Deficiency Exposed to Nitrous Oxide
J Pediatr 137:427-428, Felmet,K. et al, 2000
Antioxidant Therapy in Neurologic Disease
Arch Neurol 57:1265-1270, Delanty,N. & Dichter,M.A., 2000
Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000
Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000
Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000